Viewing Study NCT01671956


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-02-22 @ 9:39 AM
Study NCT ID: NCT01671956
Status: TERMINATED
Last Update Posted: 2025-11-25
First Post: 2012-08-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis
Sponsor: Alexion Pharmaceuticals, Inc.
Organization: